Concepts and Core Principles of Fragment-Based Drug Design

被引:139
|
作者
Kirsch, Philine [1 ,2 ]
Hartman, Alwin M. [1 ,3 ]
Hirsch, Anna K. H. [1 ,3 ]
Empting, Martin [1 ,2 ]
机构
[1] Helmholtz Ctr Infect Res HZI, Helmholtz Inst Pharmaceut Res Saarland HIPS, Dept Drug Design & Optimizat DDOP, Campus E8-1, D-66123 Saarbrucken, Germany
[2] Saarland Univ, Dept Pharm, Campus E8-1, D-66123 Saarbrucken, Germany
[3] Univ Groningen, Stratingh Inst Chem, Nijenborgh 7, NL-9747 AG Groningen, Netherlands
来源
MOLECULES | 2019年 / 24卷 / 23期
关键词
fragment-based drug design; biophysical screening; rule-of-three; ligand efficiency; fragment optimization; DIFFERENTIAL SCANNING FLUOROMETRY; DYNAMIC COMBINATORIAL CHEMISTRY; SURFACE-PLASMON RESONANCE; THERMAL SHIFT ASSAYS; MICROSCALE THERMOPHORESIS; HIGH-THROUGHPUT; PSEUDOMONAS-AERUGINOSA; LIGAND INTERACTIONS; HIT IDENTIFICATION; CHEMICAL SPACE;
D O I
10.3390/molecules24234309
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this review, a general introduction to fragment-based drug design and the underlying concepts is given. General considerations and methodologies ranging from library selection/construction over biophysical screening and evaluation methods to in-depth hit qualification and subsequent optimization strategies are discussed. These principles can be generally applied to most classes of drug targets. The examples given for fragment growing, merging, and linking strategies at the end of the review are set in the fields of enzyme-inhibitor design and macromolecule-macromolecule interaction inhibition. Building upon the foundation of fragment-based drug discovery (FBDD) and its methodologies, we also highlight a few new trends in FBDD.
引用
收藏
页数:22
相关论文
共 50 条
  • [41] Fragment-based drug design facilitates selective kinase inhibitor
    Wang, Zhi-Zheng
    Shi, Xing-Xing
    Huang, Guang-Yi
    Hao, Ge-Fei
    Yang, Guang-Fu
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2021, 42 (07) : 551 - 565
  • [42] Fragment-based drug design: How big is too big?
    Hajduk, Philip J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (24) : 6972 - 6976
  • [43] A computational protocol to fragment-based drug design at PDB scale
    F Moriaud
    T Henry
    SA Adcock
    AM Vorotynsev
    L Martin
    O Doppelt
    AG De Brevern
    F Delfaud
    Chemistry Central Journal, 2 (Suppl 1)
  • [44] Design and synthesis of dihydroisoquinolones for fragment-based drug discovery (FBDD)
    Palmer, Nick
    Peakman, Torren M.
    Norton, David
    Rees, David C.
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2016, 14 (05) : 1599 - 1610
  • [45] Library Design Strategies To Accelerate Fragment-Based Drug Discovery
    Troelsen, Nikolaj S.
    Clausen, Mads H.
    CHEMISTRY-A EUROPEAN JOURNAL, 2020, 26 (50) : 11391 - 11403
  • [46] Fragment-based drug design of nature-inspired compounds
    Najjar, Abdulkarim
    Olgac, Abdurrahman
    Ntie-Kang, Fidele
    Sippl, Wolfgang
    PHYSICAL SCIENCES REVIEWS, 2019, 4 (09)
  • [47] Fragment-based lead design
    Tarasova, Olga A.
    Poroikov, V. V.
    RUSSIAN CHEMICAL REVIEWS, 2012, 81 (02) : 158 - 174
  • [48] In Silico Fragment Screening by Replica Generation (FSRG) Method for Fragment-Based Drug Design
    Fukunishi, Yoshifumi
    Mashimo, Tadaaki
    Orita, Masaya
    Ohno, Kazuki
    Nakamura, Haruki
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2009, 49 (04) : 925 - 933
  • [49] Experiences in fragment-based drug discovery
    Murray, Christopher W.
    Verdonk, Marcel L.
    Rees, David C.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2012, 33 (05) : 224 - 232
  • [50] The rise of fragment-based drug discovery
    Murray, Christopher W.
    Rees, David C.
    NATURE CHEMISTRY, 2009, 1 (03) : 187 - 192